Fabhalta is now approved by the FDA as an oral medication for paroxysmal nocturnal hemoglobinuria.

Published Date: 11 Dec 2023

For adults with paroxysmal nocturnal seizures, the US Food and Drug Administration has approved Fabhalta® (iptacopan) as the initial oral monotherapy.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Common intracellular toxin could help fight leukemia

2.

CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma

3.

Scholastic performance is a key concern for young cancer patients, study finds

4.

AACR: American Association for Cancer Research

5.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot